Latest news with #QIMC
Associated Press
17 hours ago
- Business
- Associated Press
DiagnaMed Announces Issuance of Restricted Share Units and Stock Options to Directors, Officers, and Consultants
Toronto, Ontario--(Newsfile Corp. - July 21, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ('DiagnaMed' or the 'Company') is pleased to announce that, in accordance with its equity incentive plan, it has issued a total of 3,000,000 restricted share units (RSUs) and 2,500,000 stock options to directors, officers, and consultants of the Company. The RSUs and options were granted as part of DiagnaMed's ongoing efforts to align the interests of its leadership and key partners with those of shareholders, and to reward contributions to the Company's continued growth and development. The 2,500,000 stock options have an exercise price of $0.05 per share and are exercisable for a period of three (3) years from the date of grant. All RSUs and options are subject to the terms and conditions of the Company's equity incentive plan and applicable regulatory approvals. These grants reflect the Board's confidence in the strategic direction of the Company, particularly as it advances its natural hydrogen projects in Ontario alongside its collaborative partners, INRS and QIMC. This initiative underscores DiagnaMed's commitment to driving innovation and growth in the natural hydrogen sector in Ontario. The Company continues to advance its hydrogen development initiatives and enhance operational execution, strategically scaling its platform to capitalize on growth opportunities within the expanding natural hydrogen sector. This includes the ongoing deployment of the QIMC and INRS teams in Northern Ontario. About DiagnaMed Holdings Corp. DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) is a Canadian technology innovator specializing in advanced hydrogen extraction technologies designed to support the rapidly growing natural hydrogen industry. Focused on commercial scalability, DiagnaMed aims to deliver cost-effective, sustainable, and efficient hydrogen solutions critical for global energy security and decarbonization. Visit For more information, please contact: John Karagiannidis, President and CEO DiagnaMed Holdings Corp. Tel: 514-726-7058 Email: [email protected] Website: Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release. Cautionary Statement Certain statements in this news release are forward-looking statements, including with respect to future plans, and other matters. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Such information can generally be identified by the use of forwarding-looking wording such as 'will', 'may', 'expect', 'could', 'can', 'estimate', 'anticipate', 'intend', 'believe', 'projected', 'aims', and 'continue' or the negative thereof or similar variations. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, including but not limited to, business, economic and capital market conditions, the ability to manage operating expenses, and dependence on key personnel. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, anticipated costs, and the ability to achieve goals. Factors that could cause the actual results to differ materially from those in forward-looking statements include, the continued availability of capital and financing, litigation, failure of counterparties to perform their contractual obligations, loss of key employees and consultants, and general economic, market or business conditions. Factors that could cause actual results to differ materially from those anticipated in these forward-looking statements are described under the caption 'Risk Factors' in Company's management's discussion and analysis for the Three and Six Months Ended March 31, 2025 ('MD&A'), dated May 28, 2025, which is available on the Company's profile at Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The reader is cautioned not to place undue reliance on any forward-looking information. The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in the United States of America. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the '1933 Act') or any state securities laws and may not be offered or sold within the United States or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available. To view the source version of this press release, please visit
Yahoo
18 hours ago
- Business
- Yahoo
DiagnaMed Announces Issuance of Restricted Share Units and Stock Options to Directors, Officers, and Consultants
Toronto, Ontario--(Newsfile Corp. - July 21, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or the "Company") is pleased to announce that, in accordance with its equity incentive plan, it has issued a total of 3,000,000 restricted share units (RSUs) and 2,500,000 stock options to directors, officers, and consultants of the Company. The RSUs and options were granted as part of DiagnaMed's ongoing efforts to align the interests of its leadership and key partners with those of shareholders, and to reward contributions to the Company's continued growth and development. The 2,500,000 stock options have an exercise price of $0.05 per share and are exercisable for a period of three (3) years from the date of grant. All RSUs and options are subject to the terms and conditions of the Company's equity incentive plan and applicable regulatory approvals. These grants reflect the Board's confidence in the strategic direction of the Company, particularly as it advances its natural hydrogen projects in Ontario alongside its collaborative partners, INRS and QIMC. This initiative underscores DiagnaMed's commitment to driving innovation and growth in the natural hydrogen sector in Ontario. The Company continues to advance its hydrogen development initiatives and enhance operational execution, strategically scaling its platform to capitalize on growth opportunities within the expanding natural hydrogen sector. This includes the ongoing deployment of the QIMC and INRS teams in Northern Ontario. About DiagnaMed Holdings Corp. DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) is a Canadian technology innovator specializing in advanced hydrogen extraction technologies designed to support the rapidly growing natural hydrogen industry. Focused on commercial scalability, DiagnaMed aims to deliver cost-effective, sustainable, and efficient hydrogen solutions critical for global energy security and decarbonization. Visit For more information, please contact: John Karagiannidis, President and CEO DiagnaMed Holdings Corp. Tel: 514-726-7058 Email: info@ Website: Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release. Cautionary Statement Certain statements in this news release are forward-looking statements, including with respect to future plans, and other matters. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Such information can generally be identified by the use of forwarding-looking wording such as "will", "may", "expect", "could", "can", "estimate", "anticipate", "intend", "believe", "projected", "aims", and "continue" or the negative thereof or similar variations. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, including but not limited to, business, economic and capital market conditions, the ability to manage operating expenses, and dependence on key personnel. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, anticipated costs, and the ability to achieve goals. Factors that could cause the actual results to differ materially from those in forward-looking statements include, the continued availability of capital and financing, litigation, failure of counterparties to perform their contractual obligations, loss of key employees and consultants, and general economic, market or business conditions. Factors that could cause actual results to differ materially from those anticipated in these forward-looking statements are described under the caption "Risk Factors" in Company's management's discussion and analysis for the Three and Six Months Ended March 31, 2025 ("MD&A"), dated May 28, 2025, which is available on the Company's profile at Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The reader is cautioned not to place undue reliance on any forward-looking information. The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in the United States of America. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "1933 Act") or any state securities laws and may not be offered or sold within the United States or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available. To view the source version of this press release, please visit
Zawya
04-07-2025
- Business
- Zawya
MPHC restructures partnership for salt production facility in Qatar
DOHA: Mesaieed Petrochemical Holding Company (MPHC) is pleased to announce a significant update following our previous announcement on 23rd September 2024. The parties has reached a mutual agreement for the exit of the Turkish partner 'Atlas' from the Memorandum of Understanding ('MoU') concerning the development and operation of a state-of-the-art salt production facility. The innovative salt production facility will now be established through a new joint venture ownership structure: Mesaieed Petrochemical Holding Company (MPHC): 60% equity stake, Qatar Industrial Manufacturing Co (QIMC): 40% equity stake This restructuring marks a pivotal step in advancing the project, ensuring streamlined operations and enhanced collaboration between the remaining partners. The facility aims to leverage cutting-edge technology to meet growing demand and contribute to Qatar's industrial diversification efforts. QAPCO remains the project development manager, providing all project-related support. Further details regarding the project will be disclosed in due course, upon reaching the (FID) stage. © Dar Al Sharq Press, Printing and Distribution. All Rights Reserved. Provided by SyndiGate Media Inc. (
Qatar Tribune
03-07-2025
- Business
- Qatar Tribune
MPHC restructures partnership for salt production facility in Qatar
Tribune News Network Doha Mesaieed Petrochemical Holding Company (MPHC) has announced a major restructuring in the partnership framework for its upcoming state-of-the-art salt production facility in Qatar. This development comes as a follow-up to the company's earlier announcement made on September 23, 2024. In a mutual agreement, the Turkish partner Atlas has exited the Memorandum of Understanding (MoU) that was initially signed for the development and operation of the facility. With this exit, the project will now move forward under a revised joint venture ownership structure comprising MPHC and Qatar Industrial Manufacturing Company (QIMC). Under the new arrangement, MPHC will hold a 60 percent equity stake while QIMC will own the remaining 40 percent. The restructuring represents a significant milestone in the project's progression, paving the way for more streamlined operations and stronger collaboration between the two Qatari entities. The planned facility is set to incorporate advanced salt production technologies, with the objective of meeting rising demand in the region and contributing to Qatar's ongoing efforts toward industrial diversification. QAPCO will continue to serve as the project development manager, providing all necessary support throughout the various phases of the project. MPHC has stated that further updates will be provided in due course, particularly as the project approaches the Final Investment Decision (FID) stage. Once completed, the cutting-edge salt production facility is expected to play a pivotal role in supporting key industrial sectors in Qatar and boosting the nation's manufacturing capabilities.
Associated Press
03-07-2025
- Business
- Associated Press
DiagnaMed Launches Ontario Hydrogen Exploration Campaign in Conjunction with QIMC and INRS; Strengthens Board
Toronto, Ontario--(Newsfile Corp. - July 3, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) ('DiagnaMed' or the 'Company'), is pleased to announce it has signed an agreement with the Institut national de la recherche scientifique (INRS) to initiate a comprehensive hydrogen exploration campaign on its Ontario properties, in conjunction with Quebec Innovative Materials Corp. (CSE: QIMC) ('QIMC'). The exploration will be led by Dr. Marc Richer-Laflèche and will include collaboration with members of the Temiscamingue First Nations. Leveraging the innovative geological exploration model successfully developed and deployed by INRS and QIMC at St-Bruno-de-Guigues, Quebec, the Ontario program will include an extensive campaign of over 2,000 soil gas samples aimed at identifying high-potential natural hydrogen zones. The INRS-QIMC exploration model has yielded exceptional results in Quebec, characterized by notably high hydrogen (H₂) measurements indicative of significant geological processes: DiagnaMed anticipates replicating this success in Ontario, significantly enhancing the understanding and valuation of its exploration assets. John Karagiannidis, President of DiagnaMed, stated, 'We are excited to launch this exploration initiative alongside QIMC and INRS. The expertise of Dr. Richer-Laflèche and our collaboration with the Temiscamingue First Nations underscore our commitment to responsible, community-engaged exploration. This campaign represents a major step forward in unlocking Ontario's natural hydrogen potential and creating sustainable value for our shareholders.' DiagnaMed is also pleased to announce important governance enhancements. The Company warmly welcomes Mr. André Turmel to its Board of Directors. Mr. Turmel brings extensive expertise in corporate governance, legal frameworks, and resource development, providing valuable strategic guidance as DiagnaMed expands its exploration initiatives. Concurrently, Mr. Carlo Sansalone has resigned from the Board. DiagnaMed expresses its sincere gratitude to Mr. Sansalone for his dedicated service and meaningful contributions to the Company's growth. About DiagnaMed Holdings Corp. DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) is a Canadian technology innovator specializing in advanced hydrogen extraction technologies designed to support the rapidly growing natural hydrogen industry. Focused on commercial scalability, DiagnaMed aims to deliver cost-effective, sustainable, and efficient hydrogen solutions critical for global energy security and decarbonization. Visit For more information, please contact: John Karagiannidis, President and CEO DiagnaMed Holdings Corp. Tel: 514-726-7058 Email: [email protected] Website: Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release. Cautionary Statement Certain statements in this news release are forward-looking statements, including with respect to future plans, and other matters. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Such information can generally be identified by the use of forwarding-looking wording such as 'will', 'may', 'expect', 'could', 'can', 'estimate', 'anticipate', 'intend', 'believe', 'projected', 'aims', and 'continue' or the negative thereof or similar variations. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, including but not limited to, business, economic and capital market conditions, the ability to manage operating expenses, and dependence on key personnel. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, anticipated costs, and the ability to achieve goals. Factors that could cause the actual results to differ materially from those in forward-looking statements include, the continued availability of capital and financing, litigation, failure of counterparties to perform their contractual obligations, loss of key employees and consultants, and general economic, market or business conditions. Factors that could cause actual results to differ materially from those anticipated in these forward-looking statements are described under the caption 'Risk Factors' in Company's management's discussion and analysis for the Three and Six Months Ended March 31, 2025 ('MD&A'), dated May 28, 2025, which is available on the Company's profile at Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The reader is cautioned not to place undue reliance on any forward-looking information. The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or view the source version of this press release, please visit
